Using machine learning algorithms and artificial intelligence could make a dramatic difference in diagnosing children with rare diseases.
A first for CHOC, a team led by Dr. Terence Sanger and Dr. Joffre Olaya treats a teen’s movement disorder through deep brain stimulation.
A new app may help reduce pain severity in children during cancer treatment, a recently published pilot study finds.
CHOC currently offers more than 140 clinical trials in varying phases, including multiple pharmaceutical industry-sponsored clinical trials.
Dr. Mary Zupanc was a key investigator in a study that led to FDA approval for a medication to treat children with Dravet syndrome.
CHOC is one of the state’s largest referral centers for the newborn screening program, which checks babies for many serious genetic disorders.